Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II cyclic doxycycline in transthyretin amyloidosis
2006-000012-24Phase 2Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxycycline in transthyretin amyloidosis (ATTR), sponsored by IRCCS San Matteo Foundation. Primary endpoints: Response, Neuropathy response and 3 more. Started Mar 2006; status: terminated.
02
Drugs
doxycycline
03
Conditions
transthyretin amyloidosis (ATTR)
Beyond the preview
Go deeper on 2006-000012-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000012-24.